Enhancing CNS mitophagy: drug development and disease-relevant models

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Mitophagy, the selective removal of damaged mitochondria, is impaired in neurodegenerative diseases (NDs), leading to neuronal dysfunction.
• Current understanding and therapeutic strategies for mitophagy activators in the central nervous system (CNS) are limited.
• Dysfunctional mitochondria accumulation contributes to neuronal damage in NDs.

Purpose of the Study:

• To review current insights into mitophagy pathways for targeting neurodegenerative diseases.
• To explore the necessary extent of mitophagy modulation for therapeutic effects in NDs.
• To highlight the complexities of mitophagy in the CNS and the need for disease-relevant models.

Main Methods:

• Literature review of recent research on mitophagy pathways and CNS applications.
• Analysis of challenges in studying mitophagy in the central nervous system.
• Discussion of in vitro model considerations for drug discovery in NDs.

Main Results:

• Identified key mitophagy pathways and modulation levels for potential therapeutic intervention in NDs.
• Highlighted significant complexities and knowledge gaps in CNS mitophagy research.
• Emphasized the need for improved, disease-relevant models for preclinical studies.

Conclusions:

• Targeting specific mitophagy pathways with appropriate modulation could offer therapeutic benefits for neurodegenerative diseases.
• Further research using advanced, CNS-specific models is essential to advance mitophagy-based therapies.
• Bridging the gap between preclinical findings and clinical application requires careful consideration of in vitro model systems.